Autophagy and Alzheimer’s disease: from molecular mechanisms to therapeutic implications MS Uddin, A Stachowiak, AA Mamun, NT Tzvetkov, S Takeda, ... Frontiers in aging neuroscience 10, 04, 2018 | 367 | 2018 |
Challenges for the pharmacological treatment of neurological and psychiatric disorders: Implications of the Ca2+/cAMP intracellular signalling interaction LB Bergantin, A Caricati-Neto European Journal of Pharmacology 788, 255-260, 2016 | 81 | 2016 |
Pharmacological implications of the Ca2+/cAMP signaling interaction: from risk for antihypertensive therapy to potential beneficial for neurological and psychiatric disorders A Caricati-Neto, AG García, LB Bergantin Pharmacology Research & Perspectives 3 (5), e00181, 2015 | 75 | 2015 |
NOVEL MODEL FOR “CALCIUM PARADOX” IN SYMPATHETIC TRANSMISSION OF SMOOTH MUSCLES: ROLE OF CYCLIC AMP PATHWAY LB Bergantin, CF Souza, R Miranda-Ferreira, SS Smaili, NH Jurkiewicz, ... Latinfarma, 121, 2014 | 71 | 2014 |
Novel model for “calcium paradox” in sympathetic transmission of smooth muscles: role of cyclic AMP pathway LB Bergantin, CF Souza, RM Ferreira, SS Smaili, NH Jurkiewicz, ... Cell Calcium 54 (3), 202-212, 2013 | 71 | 2013 |
Activating cAMP/PKA signaling in skeletal muscle suppresses the ubiquitin-proteasome-dependent proteolysis: implications for sympathetic regulation WA Silveira, DA Gonçalves, FA Graça, AL Andrade-Lopes, LB Bergantin, ... Journal of Applied Physiology 117 (1), 11-19, 2014 | 46 | 2014 |
A Calcium Paradox in the Context of Neurotransmission LB Bergantin, A Jurkiewicz, AG García, A Caricati-Neto Journal of Pharmacy and Pharmacology-David Publishing 3, 253-261, 2015 | 35 | 2015 |
Recent advances in pharmacotherapy of neurological and psychiatric disorders promoted by discovery of the role of Ca2+/cAMP signaling interaction in the neurotransmission and … LB Bergantin, A Caricati-Neto Adv Pharmac J 1 (3), 66, 2016 | 30 | 2016 |
Novel insights for therapy of Parkinson’s disease: Pharmacological modulation of the Ca2+/cAMP signalling interaction LB Bergantin, A Caricati-Neto Austin Neurol & Neurosci 1 (2), 1009, 2016 | 29 | 2016 |
Insight from “Calcium Paradox” due to Ca2+/cAMP interaction: novel pharmacological strategies for the treatment of depression LB Bergantin, A Caricati-Neto Int Arch Clin Pharmacol 2 (007), 2016 | 27 | 2016 |
Debating the “bidirectional link” between diabetes and depression through the Ca2+/cAMP signalling: Off-label effects of Ca2+ channel blockers LB Bergantin Pharmacological Research 141, 298-302, 2019 | 23 | 2019 |
From discovering "calcium paradox" to Ca2+/cAMP interaction: Impact in human health and disease LB Bergantin, A Caricati-Neto Scholars´ Press, 2016 | 22 | 2016 |
Hypertension, diabetes and neurodegenerative diseases: is there a clinical link through the Ca2+/cAMP signalling interaction? LB Bergantin Current hypertension reviews 15 (1), 32-39, 2019 | 20 | 2019 |
The passion of a scientific discovery: the “calcium paradox” due to Ca2+/camp interaction A Caricati-Neto, LB Bergantin pharmacotherapy 7, 8, 2017 | 18 | 2017 |
Pharmacological modulation of neural Ca2+/camp signaling interaction as therapeutic goal for treatment of Alzheimer× s disease A Caricati-Neto, LB Bergantin J Syst Integr Neurosci 3, e00181, 2017 | 18 | 2017 |
Insights for the inhibition of cancer progression: Revisiting Ca2+ and cAMP signalling pathways PR Errante, A Caricati-Neto, LB Bergantin Adv Cancer Prev 2, 1-2, 2017 | 18 | 2017 |
New therapeutic strategy of Alzheimer’s and Parkinson’s diseases: pharmacological modulation of neural Ca/cAMP intracellular signaling interaction 2 A Caricati-Neto, LB Bergantin Asian J Pharm Pharmacol 2 (6), 136-143, 2016 | 18 | 2016 |
From a “eureka insight” to a novel potential therapeutic target to treat Parkinson× s disease: The Ca2+/camp signalling interaction A Caricati-Neto, LB Bergantin J Syst Integr Neurosci 4 (2), 454-463, 2017 | 17 | 2017 |
Challenges for the pharmacological treatment of dementia: Implications of the Ca2+/cAMP Intracellular Signalling Interaction LB Bergantin, A Caricati-Neto Avid science, 2-25, 2016 | 17 | 2016 |
Diabetes and cancer: debating the link through Ca2+/cAMP signalling LB Bergantin Cancer letters 448, 128-131, 2019 | 16 | 2019 |